Associated symptoms that should prompt immediate medical attention include: Persistent nausea and vomiting that prevents oral intake Abdominal tenderness and distension Fever and rapid heart rate Jaundice (yellowing of skin or eyes) in cases involving biliary obstruction If severe, persistent upper abdominal pain occurs, patients should stop their GLP-1 injection immediately and seek urgent medical assessment
In 2022, WeightWatchers was removed from the NHS National Diabetes Prevention Programme following comparatively weaker results
Multi-receptor agonists target complementary pathways to enhance appetite suppression, insulin secretion, fat oxidation, and energy expenditure compared to GLP-1 monotherapy (Table 2)
The best results occur when treatment is individualized and combined with nutrition, activity, sleep, stress management, and ongoing medical support
Many highlight coaching as the biggest value
FDA Approves New Medication for Chronic Weight Management. FDA , 8 Nov